ClinicalThought

Share

Program Content

Activities

  • CAR T for R/R MM
    Adding Idecabtagene Vicleucel to the Treatment Armamentarium for Relapsed/Refractory Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2021

    Expires: June 01, 2022

  • Delayed CAR T-Cell AEs
    Identifying and Managing Delayed Adverse Events Associated With CAR T-Cell Therapy
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 05, 2021

    Expires: August 04, 2022

Faculty

cover img faculity

Caron Jacobson, MD

Associate Professor of Medicine
Harvard Medical School
Medical Director, Immune Effector Cell Therapy Program
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb